A Retrospective Study to Describe Real-World Treatment Patterns and Clinical Outcomes Among Patients With Myelodysplastic Syndromes

NCT06581055 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Myelodysplastic Syndromes (MDS)

Interventions

DRUG: Luspatercept
DRUG: Epoetin Alfa

Sponsor

Bristol-Myers Squibb